Neuromuscular Electrical Stimulation Improves Activities of Daily Living Post Stroke: A Systematic Review and Meta-analysis.
Malene Glavind Holmsted Kristensen, Henriette Busk, Troels Wienecke
PMID 35282150WHAT IT FOUND
NMES produced a moderate improvement in daily living scores for 428 post-stroke patients across 10 trials, but did not improve motor ability.
The benefit was strongest in the subacute stage and for the upper limb. No adverse effects were reported.
Key findings
01NMES improved ADL scores compared with control (SMD 0.41; 95% CI 0.14 to 0.67; P = .003) across 10 trials and 428 participants.
02NMES did not improve functional motor ability (SMD 0.15; 95% CI -0.13 to 0.43; P = .30) across 13 trials and 659 participants.
03The ADL benefit was significant in the subacute stage (P = .01) and for the upper extremity (P = .02), but not in the chronic stage (P = .16) or for the lower extremity (P = .07).
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Mean PEDro score was 5.8 out of 10, which the authors rate as fair quality. None of the 20 trials used blinded therapists, and only 2 blinded participants, so performance bias is a real concern. The protocol was not preregistered, which the authors acknowledge introduces the possibility of reporting bias. The search was limited to English-language publications and no grey literature was included. No trials included patients with mild paresis, and very few covered the acute (first week) or chronic (beyond 6 months) stages, so the findings cannot be generalised to those populations. Stimulation parameters varied widely across trials (frequency, pulse width, session duration, number of channels), and no two studies used the same protocol, making it hard to identify what specifically produced the effect. The intervention group received NMES outside formal therapy sessions, adding extra therapy time. The authors themselves note that time in therapy is a known predictor of recovery and that this may account for part of the ADL benefit. The motor ability subgroup for severe paresis included only 4 studies, and the authors caution that half the studies were excluded from that subgroup due to poor data reporting.
The easy way to misread this
Do not read the ADL improvement as evidence that NMES improves motor strength or movement quality. The motor ability outcome was not significant (P = .30), and the ADL benefit may partly reflect the extra therapy time the stimulation group received outside formal sessions rather than the electrical stimulation itself.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →